Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14647671 | 1.00 | DPP7 (0.39) | DPP7MEN1KMT2ATDP1ABCB1 | |
| SCHEMBL25312085 | 0.85 | DPP7 (0.36) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL10789982 | 0.85 | DPP7 (0.36) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL25313576 | 0.85 | DPP7 (0.36) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL339384 | 0.83 | DPP7 (0.35) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL25312712 | 0.83 | DPP7 (0.35) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL25315899 | 0.83 | DPP7 (0.35) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL14861702 | 0.83 | DPP7 (0.35) | DPP7MEN1KMT2AABCB1 | |
| SCHEMBL23390989 | 0.83 | DPP7 (0.44) | DPP7ABCB1 | |
| SCHEMBL6567356 | 0.82 | DPP7 (0.33) | DPP7MEN1KMT2AABCB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230365602-A1 | COMPOUND FOR USE IN THE TREATMENT OF PROTOZOAL DISEASES AND PROCESS FOR PRODUCTION OF SAID COMPOUND | QUADREL S.R.L. (IT) | 2023-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230365602-A1 | COMPOUND FOR USE IN THE TREATMENT OF PROTOZOAL DISEASES AND PROCESS FOR PRODUCTION OF SAID COMPOUND | PIGO, PIGS, AGPS | DPP7 1519/4885MEN1 609/4885KMT2A 1697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.